Table
|  |  | ETP n = 70 | Near-ETP n = 52 | Non-ETP n = 235 | p-value |
|---|---|---|---|---|---|
| Â | Â | n (%); Median (Inter Quartile Range) | |||
Sex | Female | 14 (20%) | 14 (27%) | 57 (24%) | 0.6 |
| Â | Male | 56 (80%) | 38 (73%) | 178 (76%) | |
Age | Â | 27 (20, 33) | 27 (20, 33) | 22 (15, 30) | 0.044 |
Diagnosis | ALL | 42 (81%) | 62 (89%) | 182 (77%) | 0.12 |
LBL (Stage IV) | 8 (11%) | 8 (11%) | 53 (23%) | ||
Remission | CR1 | 66 (94%) | 48 (92%) | 211 (90%) | 0.5 |
CR2 | 66 (94%) | 4 (7.7%) | 24 (10%) | ||
Pre-HCT MRD | Positive | 26 (37%) | 22 (42%) | 61 (26%) | 0.028 |
Conditioning | Bu/Cy | 60 (86%) | 49 (94%) | 200 (85%) | 0.3 |
TBI/Cy | 10(15%) | 3(6%) | 35 (15%) | ||
Donor | MSDs | 6 (8.6%) | 10 (19%) | 30 (13%) | 0.2 |
HIDs | 64 (91%) | 42 (81%) | 205 (87%) | ||
Graft | BM + PB | 47 (67%) | 38 (73%) | 171(73%) | 0.6 |
PB | 23 (33%) | 14 (27%) | 64 (27%) | ||
